Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.
EClinicalMedicine
; 62: 102136, 2023 Aug.
Article
de En
| MEDLINE
| ID: mdl-37593221
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Guideline
Langue:
En
Journal:
EClinicalMedicine
Année:
2023
Type de document:
Article
Pays d'affiliation:
Chine